Excited to share practice-changing results of our PREOXI trial showing preoxygenation with non-invasive ventilation safely reduced hypoxemia by 51% during emergency tracheal intubation @PCCRG@CUEmergency@CUCombatCenter#CCR24
https://t.co/bJzaB0otgs
Miss the @PCCRG DEVICE trial, presented by Matthew Semler & Matthew Prekker at the Critical Care Reviews Meeting #CCR23 last week?
It was simultaneously published in @NEJM
https://t.co/3MobsWJfmh
Here, the trialists briefly explain the results
Off schedule but super excited to have the opportunity to sit down with Matt Prekker from the @PCCRG who just presented the DEVICE trial published in @NEJM today and presented at the @CritCareReviews meeting 2023
DEVICE: https://t.co/czd7zvCpuZ
Coming up in a few minutes, Matt Prekker and Matt Semler present the #DEVICEtrial at #CCR23. The @PCCRG conducted the largest randomized trial of video vs direct laryngoscopy in critically ill adults. Answer to this question in a few minutes https://t.co/OQVA4PykPM
Individualized Treatment Effects of Bougie versus Stylet for Tracheal Intubation in Critical Illness | American Journal of Respiratory and Critical Care Medicine https://t.co/KiF1l7995U
@DogICUma@VR_Cornelius @BodilSRasmussen @JonathanCaseyMD@toddrice_ICU@PCCRG The trial results are being freely livestreamed
Monday Oct 24th, 8pm UTC+1
Faculty includes chief investigators for
➡️PILOT
➡️O2-ICU
➡️HOT-ICU
➡️LOCO2
➡️ICU-ROX
➡️ongoing MEGA-ROX
https://t.co/46GjQG72L9
See you on Monday!
15/16
@DogICUma@VR_Cornelius @BodilSRasmussen @JonathanCaseyMD@toddrice_ICU Enter the PILOT trial from @PCCRG
➡️Pragmatic Investigation of optimaL Oxygen Targets
➡️2500 patients
➡️randomised cluster-crossover trial
➡️SpO2 90% v 94% v 98%
1⃣ outcome ventilator-free days at D28
14/16
3b. To deal with this uncertainty the @PCCRG is proactively (often with minimal resources...) running trials to address some "we do this every day without really knowing whether it's helpful or harmful" issues, like the PREPARE-II trial
https://t.co/xQ1JNF8nZj